Site is Being Upgraded

Dietary fibre-based therapy for body weight control, energy homeostasis and TIIDM: Inulin (fructans),  a polysaccharide isolated from chicory, inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 5/April/2018, 12.51 am

A sweet way to say no to weight gain and Diabetes: Sugar-based therapy for body weight control, energy homeostasis and TIIDM: Raffinose, a trisaccharide isolated from cotton seed flour, decreases CADM1 and its downstream target genes that inhibit glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 5/April/2017, 12.39 am
April 4, 2018
A sweet way to say no to metabolic disease: Sugar-based therapy for TIIDM and obesity-associated metabolic deficits: D-Mannose, a C-2 epimer of Glucose,, increases Lipocalin 2 (LCN2) expression, activates an MC4R-dependent anorexigenic pathway, suppresses appetite and weight gain, increases insulin secretion, improves glucose tolerance, promotes glucose homeostasis, improves obesity-associated metabolic deficits and prevents progression to TIIDM via down regulation of its target gene, 5/April/2018, 1.05 am
April 4, 2018
Show all

Introduction: What they say 

A study from Nutritional Sciences and Toxicology Department, University of California, Berkeley, Berkeley, United States shows that “Dnmt3a is an epigenetic mediator of adipose insulin resistance.” This research paper was published, in the 1 Nov 2017 issue of the journal “Elife”, by Prof.Kang S, You D and others.


What we say:

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Dietary fibre-based therapy for body weight control, energy homeostasis and TIIDM: Inulin (fructans),  a polysaccharide isolated from chicory, inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up regulation of its target gene


From significance of the study to public health relevance:

Given that: (1) more than 387 million people worldwide are affected by Diabetes mellitus (DM); (2) Diabetes is going to be one of the top 10 causes of death by 2030; (3) the life-long painful injection/drug treatment is required to treat DM; (3) the global economic cost spent for diabetes treatment in 2014 was little more than 600 billion US dollars, there is an urgent need to find: (i) a way to induce regeneration of adult ß-cells that were lost in DM; (ii) a cheaper alternative to the existing expensive weight-loss drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, diabetes.


What is known?

Prof.Kang’s research team has recently shown that:(1) DNA methyltransferase 3a (Dnmt3a) promotes insulin resistance; (2) DNMT3a null mice are resistant to diet-induced insulin resistance and glucose intolerance; (3) FGF21 is a negative target of DNMT3a gene and its promoter region is heavily methylated in patients with diabetes; and (4) FGF21 induction attenuates Dnmt3a-mediated insulin resistance, suggesting that decreasing the expression of DNMT3a may result in (a) induction of FGF21; (b) increased insulin sensitivity and glucose tolerance; and (3) attenuation of Obesity-associated TIIDM.


From research findings to Therapeutic opportunity:

This study suggests a dietary-based therapy for Obesity-associated TIIDM.  Inulin, by increasing the expression of its target gene, it may decrease the expression of DNMT3a. Thereby, it may: (1) decrease methylation at the FGF21 promoter region; (2) increase FGF21 expression; (3) augment insulin sensitivity; (4) increase glucose tolerance; and (5) inhibit diet-induced insulin resistance (Fig.1). Thus, pharmacological mixture encompassing “Inulin or its analogues, either alone or in combination with compounds,” may be used to treat Obesity-associated TIIDM (Fig.2).

Figure 1. Mechanistic insights into dietary fibre Inulin attenuates insulin resistance and cardiac ageing. Inulin, by inhibiting DNMT3a expression, induces FGF21 expression, promotes regeneration, attenuates insulin resistance and cardiac ageing and promotes longevity

Figure 2. Dietary fibre Inulin attenuates weight gain, insulin resistance, diabetic cardiomyopathy, myocardial infarction and cardiac ageing through induction of FGF21


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does Inulin decrease the expression of DNMT3a to promote insulin sensitivity?

Amount: $500#

# Research cooperation

For purchase and payment details, you may reach us at info@genomediscovery.org


References:

Web: http://genomediscovery.org or http://newbioideas.com

Citation: Boominathan, L., Dietary fibre-based therapy for body weight control, energy homeostasis and TIIDM: Inulin (fructans), a polysaccharide isolated from chicory, inhibits DNA methyltransferase 3a (Dnmt3a) expression, increases FGF21 expression, augments insulin sensitivity, increases glucose tolerance, and protects from diet-induced obesity and TIIDM, via up regulation of its target gene, 5/April/2018, 12.51 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite, drop us a line at info@genomediscovery.org

Comments are closed.